Post Translational Modifications and Autoimmunity
Post Translational Modifications and Autoimmunity
批准号:
6877090
负责人:
Mark J Mamula
金额:
$32.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2007-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It is the principle purpose of the immune
system to protect the host from infectious pathogenic microorganisms. With that
purpose in mind, lymphocytes have been programmed to differentiate self tissue
antigens from foreign antigen. However, the appearance of autoimmune diseases
and the presence of autoreactive lymphocytes in the normal population
illustrates that the regulation of immunity is far from perfect. Systemic
autoimmune diseases are the product of a complex interaction of lymphocytes,
soluble macromolecules, and self tissues leading to the pathology of disease.
Autoimmune responses often target multiple determinants within an autoantigen.
For example, in systemic lupus erythematosus (SLE), autoantibodies are directed
at a number of determinants on small nuclear ribonucleoproteins (snRNPs) and on
nucleosomes. The self or foreign proteins involved in the spontaneous
initiation of these autoimmune responses is not known.
We have recently identified the ability of a novel post-translational protein
modification, termed isoaspartyl, to confer autoimmunity to otherwise
immunologically inert self peptides. For example, the immunization with
isoaspartyl forms of snRNPs can provoke autoantibody responses typical of human
SLE. Isoaspartyl peptide modifications arise frequently in aged and stressed
cells. This application will examine the presence of isoaspartyl forms of lupus
autoantigens in resting, aged, and activated lymphocyte populations and
determine their ability to circumvent immune tolerance. Second, we will examine
the immunologic abnormalities, lymphokine responses and intracellular
signalling, in murine models unable to repair isoaspartyl modifications (PIMT
knockout mice). Finally, we will study the progression of spontaneous lupus
autoimmunity and pathology in MRL Lpr/lpr-PIMT-/- mice, a murine model of human
SLE.
This application will define the biological and immunological implications of
post-translational protein modifications. Overall, our studies will address
mechanisms important in the induction and perpetuation of autoimmune disease. A
more thorough understanding of the earliest events in the genesis of
autoimmunity may help identify important elements to exploit for the
immunologic intervention of these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity
-
批准号:9909591
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2019
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8647974
-
项目类别:
-
资助金额:$26.29万
-
财政年份:2013
-
负责人:Mark J Mamula
-
依托单位:
In Vito Imaging
-
批准号:7673607
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2008
-
负责人:Mark J Mamula
-
依托单位:
Mechanisms of Antigen Trafficking in Autoimmunity
-
批准号:7680476
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2008
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:7330500
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8150350
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
Mechanisms of Antigen Trafficking in Autoimmunity
-
批准号:7352535
-
项目类别:
-
资助金额:$4.13万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
In Vito Imaging
-
批准号:7352530
-
项目类别:
-
资助金额:$13.18万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
EGFR Peptides as Vaccines in Anti-Tumor Immunity
-
批准号:8000852
-
项目类别:
-
资助金额:$62.87万
-
财政年份:2007
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:6742316
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:7288356
-
项目类别:
-
资助金额:$57.48万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Modified HER-2 Tumor Antigens for Vaccination in Cancer
-
批准号:7158302
-
项目类别:
-
资助金额:$55.29万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Isoaspartyl Modified Tumor Antigens for Vaccination
-
批准号:6840749
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2004
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6337076
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6511529
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:7464321
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:8240037
-
项目类别:
-
资助金额:$40.55万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications in Tolerance and Autoimmunity
-
批准号:8971933
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
Post Translational Modifications and Autoimmunity
-
批准号:6632440
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
ROLE OF SELF PEPTIDES IN TOLERANCE AND AUTOIMMUNITY
-
批准号:6484674
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2001
-
负责人:Mark J Mamula
-
依托单位:
海外基金